 |
PDBsum entry 1f2q
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1f2q
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
95:951-961
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the human high-affinity IgE receptor.
|
|
S.C.Garman,
J.P.Kinet,
T.S.Jardetzky.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Allergic responses result from the activation of mast cells by the human
high-affinity IgE receptor. IgE-mediated allergic reactions may develop to a
variety of environmental compounds, but the initiation of a response requires
the binding of IgE to its high-affinity receptor. We have solved the X-ray
crystal structure of the antibody-binding domains of the human IgE receptor at
2.4 A resolution. The structure reveals a highly bent arrangement of
immunoglobulin domains that form an extended convex surface of interaction with
IgE. A prominent loop that confers specificity for IgE molecules extends from
the receptor surface near an unusual arrangement of four exposed tryptophans.
The crystal structure of the IgE receptor provides a foundation for the
development of new therapeutic approaches to allergy treatment.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Identification of the Fc epsilon
RI-Binding Site for IgE(A) Residues of Fc epsilon
RI implicated in binding IgE, shown in three orientations of the
receptor (side and top views). Residues that have been
identified by mutagenesis studies in forming the binding site
for the IgE-Fc are shown in yellow. Two residues that affect Fc
epsilon
RI binding to a mutant IgE-Fc (R334S) are shown in magenta.
Carbohydrate attachment sites for all of the human and nonhuman
receptors in Table 2 are colored gray in the Cα track. Note
that the carbohydrate sites cover a substantial portion of the
FcR surface, but they do not impinge on the binding site region
identified by mutagenesis.(B) A surface representation of the
IgE receptor showing the surface exposure of aromatic residues
in blue. The patch corresponding to the four tryptophans is
indicated. Aromatic residues that form part of the predicted
IgE-binding site are also evident in the D2 C-C′ region.
|
 |
Figure 5.
Figure 5. Implications for Fc epsilon
RI Specificity and Its Interaction with IgE(A) Four
surface-exposed tryptophans at the top of the D2 domain that are
implicated in IgE binding.(B) Residues in the D2-FG loop and
D1-E strand that are highly variable in human FcR sequences. The
residues in the D2-FG loop have been directly implicated in IgE
binding (see text). The residues in the D1-E strand and the
D1-A′B loop are located near the top of the D2 domain and
could form part of an extended IgE-binding surface between the
two domains. Note that the carbohydrate attachment sites shown
in Figure 4A are consistent with a continuous Fc-binding surface
spanning the two domains involving these D1 loop regions.(C)
Juxtaposition of Fc epsilon
RI with a model for the intact IgE antibody structure. The IgE
model is derived from the intact IgG1 antibody ([17]). The
insertion of the C epsilon
2 domains in the IgE molecule is indicated by dotted lines. The
Fc epsilon
RI α chain is shown relative to the mast cell membrane near the
top of the C epsilon
3 domains that bind to the receptor.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1998,
95,
951-961)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Kim,
A.Eggel,
S.S.Tarchevskaya,
M.Vogel,
H.Prinz,
and
T.S.Jardetzky
(2012).
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
|
| |
Nature,
491,
613-617.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.J.Rosenwasser
(2011).
Mechanisms of IgE Inflammation.
|
| |
Curr Allergy Asthma Rep,
11,
178-183.
|
 |
|
|
|
|
 |
M.D.Holdom,
A.M.Davies,
J.E.Nettleship,
S.C.Bagby,
B.Dhaliwal,
E.Girardi,
J.Hunt,
H.J.Gould,
A.J.Beavil,
J.M.McDonnell,
R.J.Owens,
and
B.J.Sutton
(2011).
Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI.
|
| |
Nat Struct Mol Biol,
18,
571-576.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.H.Schein,
O.Ivanciuc,
T.Midoro-Horiuti,
R.M.Goldblum,
and
W.Braun
(2010).
An Allergen Portrait Gallery: Representative Structures and an Overview of IgE Binding Surfaces.
|
| |
Bioinform Biol Insights,
4,
113-125.
|
 |
|
|
|
|
 |
B.A.Wurzburg,
and
T.S.Jardetzky
(2009).
Conformational flexibility in immunoglobulin E-Fc 3-4 revealed in multiple crystal forms.
|
| |
J Mol Biol,
393,
176-190.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Nimmerjahn,
and
J.V.Ravetch
(2008).
Fcgamma receptors as regulators of immune responses.
|
| |
Nat Rev Immunol,
8,
34-47.
|
 |
|
|
|
|
 |
H.J.Gould,
and
B.J.Sutton
(2008).
IgE in allergy and asthma today.
|
| |
Nat Rev Immunol,
8,
205-217.
|
 |
|
|
|
|
 |
T.I.Arnon,
J.T.Kaiser,
A.P.West,
R.Olson,
R.Diskin,
B.C.Viertlboeck,
T.W.Göbel,
and
P.J.Bjorkman
(2008).
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.
|
| |
J Mol Biol,
381,
1012-1024.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Peters,
M.Bacher,
C.L.Buenemann,
F.Kricek,
J.M.Rondeau,
and
K.Weigand
(2007).
Conformationally constrained mimics of the membrane-proximal domain of Fc epsilonRIalpha.
|
| |
Chembiochem,
8,
1785-1789.
|
 |
|
|
|
|
 |
J.Abramson,
and
I.Pecht
(2007).
Regulation of the mast cell response to the type 1 Fc epsilon receptor.
|
| |
Immunol Rev,
217,
231-254.
|
 |
|
|
|
|
 |
S.Kraft,
and
J.P.Kinet
(2007).
New developments in FcepsilonRI regulation, function and inhibition.
|
| |
Nat Rev Immunol,
7,
365-378.
|
 |
|
|
|
|
 |
M.M.Gomes,
and
A.B.Herr
(2006).
IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.
|
| |
Springer Semin Immunopathol,
28,
383-395.
|
 |
|
|
|
|
 |
A.Nakamura,
K.Akiyama,
and
T.Takai
(2005).
Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
|
| |
Expert Opin Ther Targets,
9,
169-190.
|
 |
|
|
|
|
 |
A.Verdoliva,
D.Marasco,
A.De Capua,
A.Saporito,
P.Bellofiore,
V.Manfredi,
R.Fattorusso,
C.Pedone,
and
M.Ruvo
(2005).
A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library.
|
| |
Chembiochem,
6,
1242-1253.
|
 |
|
|
|
|
 |
J.A.Poole,
and
L.J.Rosenwasser
(2005).
The role of immunoglobulin E and immune inflammation: implications in allergic rhinitis.
|
| |
Curr Allergy Asthma Rep,
5,
252-258.
|
 |
|
|
|
|
 |
J.Agniswamy,
B.Lei,
J.M.Musser,
and
P.D.Sun
(2004).
Insight of host immune evasion mediated by two variants of group a Streptococcus Mac protein.
|
| |
J Biol Chem,
279,
52789-52796.
|
 |
|
|
|
|
 |
J.M.Woof,
and
D.R.Burton
(2004).
Human antibody-Fc receptor interactions illuminated by crystal structures.
|
| |
Nat Rev Immunol,
4,
89-99.
|
 |
|
|
|
|
 |
A.B.Herr,
E.R.Ballister,
and
P.J.Bjorkman
(2003).
Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
|
| |
Nature,
423,
614-620.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.A.Wurzburg,
and
T.S.Jardetzky
(2003).
The IgA receptor complex: a two-for-one deal.
|
| |
Nat Struct Biol,
10,
585-587.
|
 |
|
|
|
|
 |
B.M.Jensen,
J.B.Hansen,
S.Dissing,
J.Gerwien,
P.S.Skov,
and
L.K.Poulsen
(2003).
Monomeric immunoglobulin E stabilizes FcepsilonRIalpha from the human basophil cell line KU812 by protecting it from natural turnover.
|
| |
Clin Exp Allergy,
33,
655-662.
|
 |
|
|
|
|
 |
H.J.Gould,
B.J.Sutton,
A.J.Beavil,
R.L.Beavil,
N.McCloskey,
H.A.Coker,
D.Fear,
and
L.Smurthwaite
(2003).
The biology of IGE and the basis of allergic disease.
|
| |
Annu Rev Immunol,
21,
579-628.
|
 |
|
|
|
|
 |
Y.Ding,
G.Xu,
M.Yang,
M.Yao,
G.F.Gao,
L.Wang,
W.Zhang,
and
Z.Rao
(2003).
Crystal structure of the ectodomain of human FcalphaRI.
|
| |
J Biol Chem,
278,
27966-27970.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Metzger
(2002).
Molecular versatility of antibodies.
|
| |
Immunol Rev,
185,
186-205.
|
 |
|
|
|
|
 |
R.S.Davis,
G.Dennis,
M.R.Odom,
A.W.Gibson,
R.P.Kimberly,
P.D.Burrows,
and
M.D.Cooper
(2002).
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.
|
| |
Immunol Rev,
190,
123-136.
|
 |
|
|
|
|
 |
S.M.Miescher,
and
M.Vogel
(2002).
Molecular aspects of allergy.
|
| |
Mol Aspects Med,
23,
413-462.
|
 |
|
|
|
|
 |
T.Kawakami,
and
S.J.Galli
(2002).
Regulation of mast-cell and basophil function and survival by IgE.
|
| |
Nat Rev Immunol,
2,
773-786.
|
 |
|
|
|
|
 |
A.Nechansky,
and
F.Kricek
(2001).
Mapping the epitope of the anti-FcepsilonRIalpha mAb15/1 to peptide epsilonRI.
|
| |
Allergy,
56,
450.
|
 |
|
|
|
|
 |
T.Takai,
K.Okumura,
and
C.Ra
(2001).
Direct expression of the extracellular portion of human FcepsilonRIalpha chain as inclusion bodies in Escherichia coli.
|
| |
Biosci Biotechnol Biochem,
65,
79-85.
|
 |
|
|
|
|
 |
C.C.Deivanayagam,
R.L.Rich,
M.Carson,
R.T.Owens,
S.Danthuluri,
T.Bice,
M.Höök,
and
S.V.Narayana
(2000).
Novel fold and assembly of the repetitive B region of the Staphylococcus aureus collagen-binding surface protein.
|
| |
Structure,
8,
67-78.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.J.Rigby,
V.C.Epa,
G.A.Mackay,
M.D.Hulett,
B.J.Sutton,
H.J.Gould,
and
P.M.Hogarth
(2000).
Domain one of the high affinity IgE receptor, FcepsilonRI, regulates binding to IgE through its interface with domain two.
|
| |
J Biol Chem,
275,
9664-9672.
|
 |
|
|
|
|
 |
M.C.Deller,
and
E.Yvonne Jones
(2000).
Cell surface receptors.
|
| |
Curr Opin Struct Biol,
10,
213-219.
|
 |
|
|
|
|
 |
T.L.Chapman,
A.P.Heikema,
A.P.West,
and
P.J.Bjorkman
(2000).
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
|
| |
Immunity,
13,
727-736.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Takai,
T.Yuuki,
N.Iwamoto-Yasue,
K.Okumura,
and
C.Ra
(2000).
Epitope analysis and primary structures of variable regions of anti-human FcepsilonRI monoclonal antibodies, and expression of the chimeric antibodies fused with human constant regions.
|
| |
Biosci Biotechnol Biochem,
64,
1856-1867.
|
 |
|
|
|
|
 |
H.Metzger
(1999).
It's spring, and thoughts turn to...allergies.
|
| |
Cell,
97,
287-290.
|
 |
|
|
|
|
 |
J.P.Kinet
(1999).
Atopic allergy and other hypersensitivities.
|
| |
Curr Opin Immunol,
11,
603-605.
|
 |
|
|
|
|
 |
L.Vangelista,
S.Laffer,
R.Turek,
H.Grönlund,
W.R.Sperr,
P.Valent,
A.Pastore,
and
R.Valenta
(1999).
The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.
|
| |
J Clin Invest,
103,
1571-1578.
|
 |
|
|
|
|
 |
P.E.Eysink,
M.H.De Jong,
P.J.Bindels,
V.T.Scharp-Van Der Linden,
C.J.De Groot,
S.O.Stapel,
and
R.C.Aalberse
(1999).
Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study.
|
| |
Clin Exp Allergy,
29,
604-610.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |